IDX184

Idenix Pharma ends development of 2 hepatitis C drugs after regulators signal further holds

Idenix Pharma ends development of 2 hepatitis C drugs after regulators signal further holds

Yahoo/AP

Idenix Drops After FDA Puts Hold on Another Hepatitis Drug

Idenix Drops After FDA Puts Hold on Another Hepatitis Drug

Minyanville

Guilt by Association = 30% Slaughter?

Guilt by Association = 30% Slaughter?

Motley Fool

Idenix Pharmaceuticals' CEO Provides Update on IDX184 Clinical Development Program Conference (Transcript)

Idenix Pharmaceuticals' CEO Provides Update on IDX184 Clinical Development Program Conference (Transcript)

Seeking Alpha

Idenix tumbles on hepatitis drug safety concerns

Idenix tumbles on hepatitis drug safety concerns

Yahoo/AP

Positive Data Released On Idenix Pharmaceuticals IDX184 Hep C Drug

Positive Data Released On Idenix Pharmaceuticals IDX184 Hep C Drug

Seeking Alpha

Idenix Will Sink Without Drug Success, Partnership

Idenix Will Sink Without Drug Success, Partnership

Motley Fool

Why Idenix Pharmaceuticals Could Dive Further

Why Idenix Pharmaceuticals Could Dive Further

Motley Fool

Idenix Drops as Hepatitis C Drug May Face Hurdles

Idenix Drops as Hepatitis C Drug May Face Hurdles

Bloomberg

Idenix Seeks Partner for Hepatitis C Combination Drug, CEO Renaud Says

Idenix Seeks Partner for Hepatitis C Combination Drug, CEO Renaud Says

Bloomberg